WNY Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

WNY Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$729K	Sell	12,655 -369	-3%	-$21.2K	0.07%	132
2026 Q1	$790K	Buy	+13,024	New	+$759K	0.08%	116
2025 Q3	$596K	Buy	13,221 +6,826	+107%	+$319K	0.06%	131
2025 Q2	$296K	Buy	6,395 +272	+4%	+$13.4K	0.03%	185
2025 Q1	$373K	Buy	6,123 +671	+12%	+$39.1K	0.04%	167
2024 Q4	$308K	Sell	5,452 -2,630	-33%	-$147K	0.04%	169
2024 Q3	$418K	Sell	8,082 -449	-5%	-$21.1K	0.05%	162
2024 Q2	$354K	Buy	8,531 +469	+6%	+$21K	0.05%	173
2024 Q1	$437K	Buy	8,062 +39	+0.5%	+$1.99K	0.07%	156
2023 Q4	$412K	Sell	8,023 -80	-1%	-$4.2K	0.07%	158
2023 Q3	$470K	Buy	8,103 +1,047	+15%	+$64.2K	0.09%	140
2023 Q2	$451K	Sell	7,056 -192	-3%	-$12.9K	0.1%	130
2023 Q1	$502K	Sell	7,248 -364	-5%	-$25.7K	0.12%	120
2022 Q4	$548K	Buy	7,612 +41	+0.5%	+$3.09K	0.15%	105
2022 Q3	$537K	Sell	7,571 -19	-0.3%	-$1.38K	0.2%	95
2022 Q2	$585K	Sell	7,590 -354	-4%	-$27K	0.2%	89
2022 Q1	$578K	Sell	7,944 -198	-2%	-$13.3K	0.18%	95
2021 Q4	$504K	Sell	8,142 -1,328	-14%	-$77.9K	0.15%	100
2021 Q3	$564K	Buy	9,470 +1,233	+15%	+$81.2K	0.19%	88
2021 Q2	$552K	Buy	8,237 +728	+10%	+$47.5K	0.2%	84
2021 Q1	$472K	Buy	7,509 +2,868	+62%	+$178K	0.19%	76
2020 Q4	$288K	Buy	+4,641	New	+$285K	0.15%	72

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WNY Asset Management's BMY Position: Q2 2026 in Review

WNY Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, selling an estimated $21.2K and leaving 12,655 shares worth $729K. The position accounts for 0.07% of the portfolio, ranked #132.

WNY Asset Management first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $790K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

WNY Asset Management held 12,655 shares of Bristol-Myers Squibb worth $729K as of Q2 2026.
WNY Asset Management sold 369 Bristol-Myers Squibb shares in Q2 2026, an estimated $21.2K.
Bristol-Myers Squibb made up 0.07% of WNY Asset Management's portfolio in Q2 2026, its #132 holding.
WNY Asset Management first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
WNY Asset Management's Bristol-Myers Squibb position peaked at $790K in Q1 2026.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on WNY Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.